CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 206 enrolled
Drug / intervention
Clinically-indicated ultrasound +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02702999
NCT02702999N/ACompleted

Determination of Abnormal Fetal Growth or Amniotic Fluid With Third Trimester Ultrasounds in Uncomplicated Pregnancies: A Randomized Trial (UP Trial)

The University of Texas Health Science Center, Houston·interventional·Posted Mar 9, 2016·Updated Sep 5, 2018

In Brief

A clinical study evaluating Clinically-indicated ultrasound and Serial third trimester ultrasound for Uncomplicated Pregnancy and Abnormal Fetal Growth or Fluid. Completed, enrolled 206 participants across 2 sites.

Detailed Summary

The purpose of this study is to see whether women at a gestational age of 30 weeks or more without comorbidities, does performance of serial 3rd trimester growth ultrasounds increase the frequency of identifying abnormalities in fetal growth or amniotic fluid, when compared with women who only receive indicated ultrasounds?

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedMar 9, 2016
Enrollment StartJun 1, 2016
Primary CompletionAug 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 10.3 years ago

Interventions

Clinically-indicated ultrasounddevice

Routine third trimester care with clinically-indicated ultrasound (control)

Serial third trimester ultrasounddevice

Ultrasound evaluation for fetal growth and amniotic fluid will be performed every 4 weeks starting at 30 weeks (intervention group). Thus, if they continue to term, there will be 3 additional ultrasounds exams (30, 34 and 38 weeks).